Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE
Sign Up
Log in
Sarepta Therapeutics Inc banner

Sarepta Therapeutics Inc
SWB:AB3A

Watchlist Manager
Sarepta Therapeutics Inc Logo
Sarepta Therapeutics Inc
SWB:AB3A
Watchlist
Price: 20 EUR 6.16%
Market Cap: €1.2B
Write Note Create Alert Ask AI

Intrinsic Value

The intrinsic value for Sarepta Therapeutics Inc (AB3A) under the Base Case is 62.6 EUR. Compared with the current market price of 20 EUR, the stock appears Undervalued by 68% .

Based on two methods:
DCF Value
€9.26
Multiples-Based Value
€115.95
DCF Value
€9.26
Multiples-Based Value
€115.95

DCF suggests overvaluation, while multiples suggest undervaluation.

AB3A Intrinsic Value
62.6 EUR
Undervaluation 68%
Intrinsic Value
Price €20
Base Case Scenario
Monitor AB3A
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €50.08
Get notified when the price drops into your buy zone
Intrinsic Value €62.6
Margin of Safety 20% €50.08
Current Price €20
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
What is Valuation History?
Ask AI Assistant
What other research platforms think about AB3A?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is AB3A valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Sarepta Therapeutics Inc.

Explain Valuation
Alternatives to AB3A

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Sarepta Therapeutics Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

SRPT Insider Trading
Buy and sell transactions by insiders

See Also

Summary
AB3A intrinsic value, competitors valuation, and company profile.
DCF Valuation
AB3A stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AB3A stock valuation using valuation multiples.
Wall St Estimates
AB3A price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AB3A stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Sarepta Therapeutics Inc listings:
NASDAQ • USD
SRPT
 LSE • USD
0L35
 F • EUR
AB3A
 XBER • EUR
AB3A
 XMUN • EUR
AB3A
Discover More
What is the Intrinsic Value of one AB3A stock?

The intrinsic value for Sarepta Therapeutics Inc (AB3A) under the Base Case is 62.6 EUR.

Is AB3A stock undervalued or overvalued?

Compared with the current market price of 20 EUR, the stock appears Undervalued by 68% .

Back to Top
ALPHA SPREAD
Follow us
Join 334,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett